Clinical Trial Update: Pharmacokinetics and Safety of HCP1105 and Co-administration of HGP0918, HGP0816 in Healthy Male Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety study of HCP1105 with co-administration of HGP0918 and HGP0816 in healthy male volunteers, sponsored by Hanmi Pharmaceutical…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• HCP1105
• HGP0816
• HGP0918

Snippet

Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Hyperlipidemias | Phase 1 | Status: COMPLETED